Thymosin Beta-4

FDA APPROVAL PENDING

Thymosin Beta-4

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

Learn more

Healing

Thymosin Beta-4

Longevity

Amino acid sequence

37

Amino acids

4004da

Molecular weight

Peptide

Type

Naturally occurring 43-amino acid peptide crucial for tissue repair, wound healing, and cellular regeneration. Promotes angiogenesis, reduces inflammation, and supports cell migration and differentiation.

Top researched benefits

Overview of Thymosin Beta-4

Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation.

tissue repair

  • Clinical trials show 67% complete healing versus 25% placebo in pressure ulcers.
  • Enhanced tissue regeneration and reduced healing time in surgical wounds.
  • Accelerated recovery in muscle, tendon, and ligament injuries.

cardiovascular

  • Phase 2b trials show 43% reduction in infarct size when given within 6 hours.

neuroprotection

  • Improved neurological outcomes and functional recovery in animal models.

Typical Dose

2-6mg per injection (varies by protocol and severity)

Frequency

Daily for acute healing, 2x weekly for maintenance/chronic conditions

Cycle Duration

2-12 weeks depending on healing needs

Storage

Reconstituted: 2-8°C, use within 14 days

Chemical Makeup

Key benefits

Systemic regenerative effects

Proven clinical efficacy

Optimal bioavailability for tissue repair

Promotes angiogenesis

Reduces inflammation

Community interest

This peptide is still gaining traction in the community.

43-Amino Acid Regenerative Peptide | Tissue Repair & Healing

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

Thymosin Beta-4 Molecular Information

View the scientifc details of Thymosin Beta-4.

37

Amino Acids

Thymosin Beta-4

Lys

Lys

Position 1

Trp

Trp

Position 2

Lys

Lys

Position 3

Leu

Leu

Position 4

Phe

Phe

Position 5

Lys

Lys

Position 6

Lys

Lys

Position 7

Ile

Ile

Position 8

Glu

Glu

Position 9

Lys

Lys

Position 10

Val

Val

Position 11

Gly

Gly

Position 12

Gln

Gln

Position 13

Asn

Asn

Position 14

Ile

Ile

Position 15

Arg

Arg

Position 16

Asp

Asp

Position 17

Gly

Gly

Position 18

Ile

Ile

Position 19

Ile

Ile

Position 20

Lys

Lys

Position 21

Ala

Ala

Position 22

Gly

Gly

Position 23

Pro

Pro

Position 24

Ala

Ala

Position 25

Val

Val

Position 26

Ala

Ala

Position 27

Val

Val

Position 28

Val

Val

Position 29

Gly

Gly

Position 30

Gln

Gln

Position 31

Ala

Ala

Position 32

Thr

Thr

Position 33

Gln

Gln

Position 34

Ile

Ile

Position 35

Ala

Ala

Position 36

Lys

Lys

Position 37

Amino acid sequence
LysinePosition 1
TryptophanPosition 2
LysinePosition 3
LeucinePosition 4
PhenylalaninePosition 5
LysinePosition 6
LysinePosition 7
IsoleucinePosition 8
Glutamic acidPosition 9
LysinePosition 10
ValinePosition 11
GlycinePosition 12
GlutaminePosition 13
AsparaginePosition 14
IsoleucinePosition 15
ArgininePosition 16
Aspartic acidPosition 17
GlycinePosition 18
IsoleucinePosition 19
IsoleucinePosition 20
LysinePosition 21
AlaninePosition 22
GlycinePosition 23
ProlinePosition 24
AlaninePosition 25
ValinePosition 26
AlaninePosition 27
ValinePosition 28
ValinePosition 29
GlycinePosition 30
GlutaminePosition 31
AlaninePosition 32
ThreoninePosition 33
GlutaminePosition 34
IsoleucinePosition 35
AlaninePosition 36
LysinePosition 37

Molecular Weight

4004Da

Chain Length

37Amino Acids

Type

Peptide

Thymosin Beta-4 Protocols

Systemic regenerative effects with proven clinical efficacy and optimal bioavailability.

GoalDosageFrequencyRoute
Acute Wound Healing1.61 week rangeSubQ
Cardiac Protection42IV bolus within 6 hours of MI
Chronic Tissue Repair62 week rangeSubQ
Neurological Recovery3072 week rangeIV infusion
General Regeneration21 week rangeSubQ

Reconstitution Instructions

Materials needed:

Thymosin β4 lyophilized powder (sterile vial)Bacteriostatic water for injection (BWFI)Sterile syringes and needlesAlcohol swabs and sterile gauze

Steps to reconstitute

  1. Allow lyophilized powder to reach room temperature before reconstitution
  2. Add bacteriostatic water slowly to vial wall, avoiding direct powder contact
  3. Gently swirl (do not shake vigorously) until completely dissolved
  4. Inspect solution for clarity—should be clear and colorless
  5. Store reconstituted solution at 2-8°C and use within 14 days
  6. Use proper aseptic technique and rotate injection sites

Thymosin Beta-4 Cycle

The Thymosin Beta-4 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2
Initial tissue response, possible mild injection site reactions
Week 2-4
Accelerated healing becomes apparent, reduced inflammation
Week 4-8
Significant tissue regeneration and functional improvement
Week 8-12
Sustained benefits and near-complete healing in responsive conditions

Dosing tools

Thymosin Beta-4 Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

mg

Enter the total amount of peptide in the vial in milligrams (as stated on the label).

The dose you want to inject per administration, in mcg or mg.

1,000 mcg = 1 mg

1 mL

2 mL

3 mL

5 mL

Custom

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

Injection Results

Based on your vial and dilution inputs.

Thymosin Beta-4

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Thymosin Beta-4 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

1mL / 100 units

5 units

0.050 mL

Reference Guide

Dosing Cycle

Peptide
Thymosin Beta-4
Dosing
2-6mg per injection (varies by protocol and severity)
Dosing Frequency
Daily for acute healing, 2x weekly for maintenance/chronic conditions
Cycle Duration
2-12 weeks depending on healing needs
Storage
Reconstituted: 2-8°C, use within 14 days

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Thymosin Beta-4 interactions with other common peptides and substances.

Healing

bpc

Longevity

BPC-157

SYNERGISTIC

Complementary healing mechanisms—Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection.

SYNERGISTIC

Healing

tb5

Longevity

TB-500

SYNERGISTIC

TB-500 is the bioactive fragment of Thymosin β4. Combined use provides full-length peptide benefits plus concentrated bioactive effects.

SYNERGISTIC

Side effects

Contraindications

Active chemotherapy treatment

Severe systemic allergies to peptides

Stop signs

Severe injection site reactions or persistent inflammation

Signs of systemic allergic reaction (rash, breathing difficulty)

Unexpected cardiovascular symptoms during treatment

Any signs of infection at injection sites

Bad signs

Cloudy or discolored solution indicating degradationCrystallization after reconstitution suggesting improper storage
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

Thymosin Beta-4Research References

Thymosin Beta-4 is a well studied compound

4Research references

Thymosin Beta-4

Thymosin Beta-4 is a well studied compound

Phase II Dry Eye Clinical Trial

72 subjects showing significant positive effects on ocular discomfort and corneal staining with excellent safety profile.

2015

Phase I Human Safety Study: Intravenous Thymosin β4

First-in-human study establishing safety and pharmacokinetics in healthy volunteers with no dose-limiting toxicity.

2010

Cardiac Protection Pilot Study: Thymosin β4 in STEMI Patients

First human study in heart attack patients demonstrating potential clinical benefits in repairing damaged tissue.

2016

Neurotrophic Keratopathy Compassionate Use Trial

Complete clearing of persistent corneal defects in most subjects using topical formulation.

2010